ROMA VINODBHAI SHAH's Insider Trades & SAST Disclosures
ROMA VINODBHAI SHAH's most recent trade in Remus Pharmaceuticals Ltd. was a Buy of 500 Equity Shares done at an average price of Rs. 55555 . Disclosure was reported to the exchange on Dec. 6, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for ROMA VINODBHAI SHAH in the Trendlyne database.
Add Superstar Alert
Share
Note
This is a custom search result for pattern ROMA VINODBHAI SHAH.To see full superstar portfolios of large investors like Jhunjhunwala, Damani and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 06 Dec 2023 | 500 | 253,100 | - | 55555 | 27,777,500 | 04 Dec 2023 04 Dec 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 04 Dec 2023 | 500 | 252,600 | - | 5564.0 | 2,781,975 | 01 Dec 2023 01 Dec 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 200 | 252,100 | - | 4949 | 989,800 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 200 | 251,900 | - | 5000 | 1,000,000 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 200 | 251,400 | - | 4800.0 | 959,990 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 200 | 250,300 | - | 5040 | 1,008,000 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 100 | 250,600 | - | 4770 | 477,000 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 100 | 251,700 | - | 4875 | 487,500 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 100 | 251,600 | - | 4845 | 484,500 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 100 | 251,500 | - | 5099 | 509,900 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 100 | 251,200 | - | 4980.0 | 497,995 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 100 | 251,100 | - | 5098.0 | 509,795 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 100 | 251,000 | - | 5049 | 504,900 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 100 | 250,900 | - | 4970 | 497,000 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 100 | 250,800 | - | 4950 | 495,000 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 100 | 250,700 | - | 4920 | 492,000 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 100 | 250,500 | - | 5097.8 | 509,775 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 100 | 250,400 (17%) | - | 4990 | 499,000 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | ROMA VINODBHAI SHAH | Promoters | Buy | 29 Sep 2023 | 100 | 250,100 | - | 4769 | 476,900 | 27 Sep 2023 27 Sep 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.